Danish pharmaceutical company ALK-Abello A/S (ALK-B.KO) said Monday it has entered into a co-promotion agreement with MSD, known as Merck in the US and Canada, for grass pollen allergy treatment Grazax in France.
Scooped by
Gilbert C FAURE
onto Allergy (and clinical immunology) |